Gene Therapy Analysis
🇺🇸 FDAExpert commentary and market intelligence for pharma strategy teams
Showing 1–8 of 8 articles
ASGCT Annual Meeting 2026: Live Event Coverage and Key Insights
6 min
Dr. Sarah MitchellFDA seeks to cut repeat work for gene therapy developers
FDA · gene therapy · 6 min
Dr. Sarah MitchellTenaya Therapeutics to Present TN-201 Gene Therapy Data for HCM on June 3, 2026
gene therapy · 7 min
Dr. Sarah MitchellEli Lilly's New Gene Therapy and Strategic Deals: Insights for Investors
gene therapy · 3 min
Dr. Sarah MitchellFetal Gene Therapy: Breaking the Taboo on Embryo Editing
gene therapy · 3 min
Dr. Sarah Mitchell23andMe Connects DNA Data with Medical Records: Implications for Pharma
2 min
Dr. Sarah MitchellIndia's Pharma Industry Goes Global: Can It Compete with China?
3 min
Dr. Sarah MitchellFDA Approval Gene Therapies: Market Analysis Post-Hemophilia Innovations
FDA · Hemophilia A · 7 min
Dr. Sarah MitchellExplore intelligence